Discover CHEST 2026 findings on CT phenotyping, TAPSE/sPAP risk scores, artesunate, telomere length and inhaled nintedanib in ...
"Passing this futility analysis is an important milestone that allows ASPIRE to continue as designed. With 378 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results